Patents by Inventor Claire F. Verschraegen

Claire F. Verschraegen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10954260
    Abstract: Organometallic compounds comprising a chloroquinoline moiety and uses of the compounds. The compounds are, for example, manganese or rhenium complexes of a ligand comprising a chloroquinoline moiety. The compounds can be used in, for example, methods of inhibiting cell growth.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: March 23, 2021
    Assignee: University of Vermont and State Agricultural College
    Inventors: William E. Geiger, Kevin Lam, Jon E. Ramsey, Claire F. Verschraegen
  • Publication number: 20200031856
    Abstract: Organometallic compounds comprising a chloroquinoline moiety and uses of the compounds. The compounds are, for example, manganese or rhenium complexes of a ligand comprising a chloroquinoline moiety. The compounds can be used in, for example, methods of inhibiting cell growth.
    Type: Application
    Filed: August 5, 2019
    Publication date: January 30, 2020
    Inventors: William E. GEIGER, Kevin LAM, Jon E. RAMSEY, Claire F. VERSCHRAEGEN
  • Patent number: 10370395
    Abstract: Organometallic compounds comprising a chloroquinoline moiety and uses the compounds. The compounds are, for example, manganese or rhenium complexes of a ligand comprising a chloroquinoline moiety. The compounds can be used in, for example, methods of inhibiting cell growth.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: August 6, 2019
    Assignee: University of Vermont and State Agricultural College
    Inventors: William E. Geiger, Kevin Lam, Jon E. Ramsey, Claire F. Verschraegen
  • Publication number: 20180022771
    Abstract: Organometallic compounds comprising a chloroquinoline moiety and uses the compounds. The compounds are, for example, manganese or rhenium complexes of a ligand comprising a chloroquinoline moiety. The compounds can be used in, for example, methods of inhibiting cell growth.
    Type: Application
    Filed: January 4, 2016
    Publication date: January 25, 2018
    Inventors: William E. GEIGER, Kevin LAM, Jon E. RAMSEY, Claire F. VERSCHRAEGEN
  • Publication number: 20080248096
    Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.
    Type: Application
    Filed: January 25, 2008
    Publication date: October 9, 2008
    Inventors: Claire F. Verschraegen, J. Vernon Knight, Nadezhda Koshkina, Brian Gilbert
  • Patent number: 7348025
    Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.
    Type: Grant
    Filed: September 16, 2003
    Date of Patent: March 25, 2008
    Assignee: Research Development Foundation
    Inventors: J. Vernon Knight, Nadezhda Koshkina, Brian Gilbert, Claire F. Verschraegen
  • Publication number: 20020020412
    Abstract: The present invention is directed to a jet nebulizer assembly for administering drugs via aerosols in a patient's home and a method of treating a cancer in a patient's home by utilizing the jet nebulizer assembly.
    Type: Application
    Filed: July 31, 2001
    Publication date: February 21, 2002
    Inventors: Brian E. Gilbert, J. Vernon Knight, Claire F. Verschraegen